Scarica l'app Stockscreener
19.41
2.76%
-0.55
Pre-mercato:
19.40
-0.01
-0.05%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché AMPH Giù?
Forum
Previsione
Precedente Chiudi:
$19.96
Aprire:
$19.94
Volume 24 ore:
1.01M
Relative Volume:
1.71
Capitalizzazione di mercato:
$855.84M
Reddito:
$720.53M
Utile/perdita netta:
$79.23M
Rapporto P/E:
11.66
EPS:
1.6648
Flusso di cassa netto:
$132.94M
1 W Prestazione:
-4.34%
1M Prestazione:
+15.06%
6M Prestazione:
-25.55%
1 anno Prestazione:
-24.21%
Intervallo 1D:
$19.15
$20.26
Intervallo di 1 settimana:
$19.15
$20.64
Portata 52W:
$16.64
$31.26
Amphastar Pharmaceuticals Inc Stock (AMPH) Company Profile
Nome
Amphastar Pharmaceuticals Inc
Settore
Telefono
909-980-9484
Indirizzo
11570 SIXTH STREET, RANCHO CUCAMONGA, CA
Compare AMPH vs TAK, HLN, TEVA, ZTS, UTHR
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AMPH
Amphastar Pharmaceuticals Inc
|
19.41 | 869.07M | 720.53M | 79.23M | 132.94M | 1.6648 |
TAK
Takeda Pharmaceutical Co Adr
|
15.42 | 49.83B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
8.87 | 40.04B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
32.56 | 39.23B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
77.26 | 33.52B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
551.47 | 23.33B | 3.17B | 1.29B | 1.01B | 27.09 |
Amphastar Pharmaceuticals Inc Stock (AMPH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-04-21 | Downgrade | Jefferies | Buy → Hold |
| 2025-12-09 | Iniziato | Barclays | Equal Weight |
| 2025-08-12 | Aggiornamento | Needham | Hold → Buy |
| 2025-05-12 | Downgrade | JP Morgan | Overweight → Neutral |
| 2025-02-04 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2024-11-22 | Iniziato | Wells Fargo | Equal Weight |
| 2024-03-05 | Iniziato | JP Morgan | Overweight |
| 2023-11-17 | Iniziato | BofA Securities | Neutral |
| 2023-07-25 | Ripresa | Jefferies | Buy |
| 2022-10-21 | Ripresa | Jefferies | Buy |
| 2022-07-29 | Iniziato | CapitalOne | Overweight |
| 2022-01-07 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2021-01-08 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2020-10-05 | Aggiornamento | Northland Capital | Market Perform → Outperform |
| 2020-05-01 | Iniziato | Northland Capital | Outperform |
| 2019-03-13 | Downgrade | Needham | Buy → Hold |
| 2019-03-13 | Downgrade | Piper Jaffray | Overweight → Neutral |
| 2018-08-10 | Reiterato | Needham | Buy |
| 2018-03-13 | Reiterato | Needham | Buy |
| 2017-12-01 | Reiterato | Needham | Buy |
| 2017-11-09 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2017-09-27 | Reiterato | Needham | Buy |
| 2017-03-14 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2016-08-09 | Reiterato | Needham | Buy |
| 2016-05-10 | Reiterato | Needham | Buy |
| 2016-02-19 | Iniziato | Wells Fargo | Outperform |
| 2015-06-19 | Reiterato | Needham | Buy |
| 2015-06-03 | Iniziato | Raymond James | Strong Buy |
| 2014-07-21 | Iniziato | Needham | Buy |
Mostra tutto
Amphastar Pharmaceuticals Inc Borsa (AMPH) Ultime notizie
Amphastar Pharmaceuticals (AMPH) Q1 2026 Earnings: EPS Misses Estimates by Wide Margin Amid Challenging QuarterFull Year Guidance - newsline.com
(AMPH) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Healthcare Stock Picks: RadNet and Amphastar to Sell, One Stock to Watch | June 2026News and Statistics - IndexBox
Amphastar Pharmaceuticals pivots to proprietary drugs, biosimilars for growth - MSN
Amphastar Pharmaceuticals Pivots to Proprietary Drugs, Biosimilars for Growth - MarketBeat
How The Investment Story For Amphastar Pharmaceuticals (AMPH) Is Evolving Without New Valuation Shifts - Yahoo Finance
Amphastar Pharmaceuticals, Inc. Shareholders Are Encouraged - GlobeNewswire
Amphastar Pharmaceuticals sees generic Atrovent fueling 2026 growth despite BAQSIMI drag - MSN
Barclays Maintains Amphastar Pharmaceuticals(AMPH.US) With Hold Rating, Cuts Target Price to $20 - Moomoo
Amphastar Pharmaceuticals Sees Generic Atrovent Fueling 2026 Growth Despite BAQSIMI Drag - MarketBeat
Amphastar (AMPH) director awarded RSUs and options with tax withholding update - Stock Titan
Amphastar Pharmaceuticals (AMPH) director receives RSUs and options grant - Stock Titan
Deflin Gayle awarded RSUs and stock options at Amphastar (NASDAQ: AMPH) - Stock Titan
Amphastar (AMPH) director Diane Gerst receives RSUs and stock option grant - Stock Titan
Amphastar Pharmaceuticals, Inc. (AMPH) Presents at Jefferies Global Healthcare Conference 2026Slideshow - Seeking Alpha
Amphastar (AMPH) holders approve directors, EY auditor and annual say-on-pay - Stock Titan
(AMPH) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Amphastar Pharmaceuticals, Inc. (AMPH) Price Target Cut to $21 At Piper Sandler Amid Pipeline Uncertainty - Yahoo Finance
Amphastar (AMPH) Q1 2026 Earnings Transcript - AOL.com
Amphastar Pharmaceuticals to Present at the 2026 Jefferies Healthcare Conference - ACCESS Newswire
(AMPH) Risk Channels and Responsive Allocation - Stock Traders Daily
Amphastar Pharmaceuticals (AMPH) Shows Modest Gains as Stock Hovers Near Key ResistanceQuality Factor - The Legal Advocate
Why Wells Fargo Lowered Amphastar Pharmaceuticals, Inc. (AMPH) Price Target to $19 - Insider Monkey
Amphastar Earnings Call Balances Growth and Margin Strain - TipRanks
Has Amphastar Pharmaceuticals Bottomed Out After Its Steep Decline - Kavout
8 Best Small Cap Pharma Stocks to Buy Right Now - Insider Monkey
Why Amphastar Pharmaceuticals (AMPH) Stock Is Trading Lower Today - Yahoo Finance
Amphastar forecasts BAQSIMI revenue flat to up low single digits, with 3% list price increase - MSN
Amphastar Pharmaceuticals Q1 2026: Revenue Miss and Pricing Pressures on BAQSIMI - IndexBox
The 5 Most Interesting Analyst Questions From Amphastar Pharmaceuticals’s Q1 Earnings Call - Yahoo Finance
Pharma Earnings Season 2026: Amphastar Flat, Eli Lilly Surges in Q1News and Statistics - IndexBox
Q1 Earnings Roundup: Amphastar Pharmaceuticals (NASDAQ:AMPH) And The Rest Of The Pharmaceuticals Segment - Yahoo Finance
There May Be Some Bright Spots In Amphastar Pharmaceuticals' (NASDAQ:AMPH) Earnings - simplywall.st
Amphastar Pharmaceuticals' (NASDAQ:AMPH) Conservative Accounting Might Explain Soft Earnings - Yahoo Finance
This Whirlpool Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday - Sahm
Wells Fargo Initiates Amphastar Pharmaceuticals(AMPH.US) With Hold Rating, Announces Target Price $19 - Moomoo
Is Amphastar Pharmaceuticals Inc (AMPH) a Bargain After 5.6% Dro - GuruFocus
Amphastar Shares Fall After Wells Fargo Downgrade - Moomoo
Amphastar Pharmaceuticals tackles BAQSIMI discount pressure, keeps sales outlook - MSN
Amphastar Pharmaceuticals Tackles BAQSIMI Discount Pressure, Keeps Sales Outlook - MarketBeat
AMPH: Proprietary and biosimilar pipeline expansion drives growth, anchored by BAQSIMI® and Primatene MIST - TradingView
How The Amphastar Pharmaceuticals (AMPH) Narrative Is Shifting As Targets Fall And New Drugs Launch - Yahoo Finance
Amphastar Pharmaceuticals (NASDAQ:AMPH) Earns Neutral Rating from Piper Sandler - MarketBeat
(AMPH) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Amphastar price target lowered to $21 from $25 at Piper Sandler - TipRanks
Earnings Miss: Amphastar Pharmaceuticals, Inc. Missed EPS By 75% And Analysts Are Revising Their Forecasts - Yahoo Finance
Amphastar Pharmaceuticals (AMPH) Margin Compression Reinforces Bearish Narrative Despite Stable Revenue - Sahm
Needham downgrades Amphastar Pharmaceuticals (AMPH) - MSN
Amphastar Pharmaceuticals (NASDAQ:AMPH) Posts Quarterly Earnings Results - MarketBeat
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Q1 2026 Earnings Call Transcript - Insider Monkey
Amphastar Pharmaceuticals Inc Azioni (AMPH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Amphastar Pharmaceuticals Inc Azioni (AMPH) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Zhou Rong | SENIOR EVP, PRODUCTION CENTER |
Dec 17 '25 |
Sale |
26.20 |
9,787 |
256,379 |
138,043 |
| Petersen Floyd F. | Director |
Dec 12 '25 |
Sale |
25.92 |
2,426 |
62,888 |
71,368 |
| Petersen Floyd F. | Director |
Dec 11 '25 |
Sale |
25.69 |
1,737 |
44,620 |
73,794 |
0.95%
1.13%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):